Skip to main navigation Skip to search Skip to main content

Correction: Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy (Journal of Pharmacology and Experimental Therapeutics (2013) 344: 1 (103-112) DOI: 10.1124/jpet.112.199109)

Research output: Contribution to journalComment/debate

Abstract

In reviewing the above article [Ait-Oudhia S, Straubinger RM, and Mager DE (2013) J Pharmacol Exp Ther 344(1): 103-112; DOI: https://doi.org/10.1124/jpet.112.199109], the authors discovered panels A and E in Figure 2 are incorrect, along with typos in several parameters (mostly units) in Table 2. The modeling and simulations have been faithfully reproduced, and these errors do not change the results and conclusions of the paper. The correct versions of Table 2 and Figure 2 appear below and in the PDF and HTML versions of this article. The authors apologize for any inconvenience caused by these errors. (Table Presented).

Original languageEnglish
Pages (from-to)365-366
Number of pages2
JournalJournal of Pharmacology and Experimental Therapeutics
Volume366
Issue number2
DOIs
StatePublished - Aug 2018

Fingerprint

Dive into the research topics of 'Correction: Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy (Journal of Pharmacology and Experimental Therapeutics (2013) 344: 1 (103-112) DOI: 10.1124/jpet.112.199109)'. Together they form a unique fingerprint.

Cite this